Jose Eades

Josh has extensive experience in the biotech and pharma industry with more than 20 years across various industries, focusing on research, quality management, and product development. Known for his ability to lead and develop teams to successfully commercialize products, Josh is responsible for the science and technical portfolio at bioLytical, leading a dynamic group of scientists to spearhead the strategy and expansion of bioLytical’s INSTI product line in the global market.

Prior to joining bioLytical in 2021, Josh held various roles across the pharma, biotech, and cannabis sectors. With a diverse background in transforming and translating research to successfully commercialize products, Josh utilizes his vast academic, research, and business background to develop and implement launch strategies to successfully manage the product lifecycle. Also, a successful entrepreneur, Josh co-founded an analytics and on-site testing company responsible for providing solutions for cannabinoid identification, quantification, and profiling, where he continues to act in a scientific advisory role.

With an impressive academic background, Josh holds a Ph.D. in Biology from the University of Victoria and has lectured at three universities. During his studies, he specialized in genetics and protein chemistry specialization.